Research
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Genetic sequencing: How do we put out the fires of genetically driven cancers?
Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
Survivorship studies dig in on data
Read how cancer survivorship research reveals more about the late effects of treatment on children – and how the data can paint a more complete picture.
Research homes in on drug to dampen inflammation fueling life-threatening immune disorder
Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.
Separating fact from fiction using pharmacogenetics
Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.
Chaperones: probing the structural secrets of the cell’s front-line protein protectors
Read how this protein, called a chaperone, does more than simply monitor the intracellular dance of protein folding – it protects them from going awry.
Rare childhood disorders widen window on diseases of aging
Read how extremely rare genetic childhood diseases offer clues about understanding neurodegenerative disorders common with aging.
PeCanPIE offers powerful tools for discovering inherited cancer genes
Powerful cancer data portal gets an upgrade to identify the genetic culprit for inherited cancer and possibly other genetic diseases.
Pediatric immunotherapy: How two immunologists are paving the way for improved treatments
Two friends and research colleagues are looking at different stages of the immune response to pave the way for enhanced cancer treatments.
Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?
High science calls on Star Wars character as a potential ally against Alzheimer’s disease.
SJELIOT clinical trial explores a new approach for recurring and unresponsive medulloblastoma tumors
St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.